A detailed history of Per Stirling Capital Management, Llc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Per Stirling Capital Management, Llc. holds 2,279 shares of NVO stock, worth $239,910. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,279
Previous 2,279 -0.0%
Holding current value
$239,910
Previous $325 Million 16.58%
% of portfolio
0.04%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$102.11 - $135.92 $32,777 - $43,630
321 Added 16.39%
2,279 $293 Million
Q4 2023

Feb 13, 2024

BUY
$87.78 - $105.45 $171,873 - $206,471
1,958 New
1,958 $203 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Per Stirling Capital Management, Llc. Portfolio

Follow Per Stirling Capital Management, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Per Stirling Capital Management, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Per Stirling Capital Management, Llc. with notifications on news.